8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione (CAS 853029-57-9)

Chemox Pharma is a leading supplier and manufacturer of 8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione (CAS No.: 853029-57-9), commonly referred to as Linagliptin Intermediate – BBQ. This key intermediate is used in the synthesis of Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor widely prescribed for the treatment of type 2 diabetes mellitus.

As an ISO 9001:2015 certified company, Chemox Pharma ensures the supply of high-quality intermediates manufactured under strict global regulatory guidelines (DCGI, WHO-GMP, FDA). Each batch is produced with high purity, consistency, and complete documentation support to meet the requirements of international pharmaceutical companies.

With a strong focus on quality assurance, transparency, and compliance, Chemox Pharma is a trusted partner for global pharma industries. Our advanced R&D Centre enables process development, optimization, and cost-effective solutions, ensuring reliable supply and regulatory excellence.

Contact us today for sourcing Linagliptin Intermediate – BBQ (CAS No.: 853029-57-9) with competitive pricing, assured quality, and timely delivery.